Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
2425 items from SEC EDGAR · clear filters
- 8-K - CITIGROUP INC (0000831001) (Filer)
Citigroup Inc filed a Form 8-K on July 14, 2026, including Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.
- 8-K - Genprex, Inc. (0001595248) (Filer)
Genprex, Inc. filed a Form 8-K reporting material modifications to security holder rights, amendments to its articles of incorporation and bylaws including a fiscal year change, a Regulation FD disclosure, other events, and related financial statements and exhibits.
- 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer)
Ligand Pharmaceuticals filed a Form 8-K reporting entry into a material definitive agreement, completion of an acquisition or disposition of assets, creation of a direct financial obligation or off-balance-sheet arrangement, a Regulation FD disclosure, and related financial statements and exhibits.
- 8-K - Federal Home Loan Bank of Pittsburgh (0001330399) (Filer)
Federal Home Loan Bank of Pittsburgh filed a Form 8-K on July 14, 2026 disclosing the creation of a direct financial obligation (or off-balance-sheet arrangement) and providing its financial statements and related exhibits.
- 8-K - AMERICAS CARMART INC (0000799850) (Filer)
Americas Carmart Inc. filed a Form 8-K on July 14, 2026, disclosing its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - Central Plains Bancshares, Inc. (0001979332) (Filer)
Central Plains Bancshares, Inc. filed a Form 8-K on July 14, 2026 reporting the departure, election or appointment of certain directors and officers and related compensatory arrangements, and included its financial statements and accompanying exhibits.
- 8-K - XOMA Royalty Corp (0000791908) (Filer)
XOMA Royalty Corp filed an 8-K reporting termination of a material definitive agreement, completion of an acquisition or asset disposition, a delisting notice, material modifications to security-holder rights, a change in control, and director/officer departures and appointments.
- 8-K - Federal Home Loan Bank of Topeka (0001325878) (Filer)
Federal Home Loan Bank of Topeka filed a Form 8-K on July 14, 2026, disclosing the creation of a direct financial obligation and/or an off-balance-sheet arrangement.
- 8-K - SUI Group Holdings Ltd. (0001425355) (Filer)
SUI Group Holdings Ltd. filed a Form 8-K on July 14, 2026, reporting departures and appointments of directors and officers, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - SPLASH BEVERAGE GROUP, INC. (0001553788) (Filer)
Splash Beverage Group, Inc. filed a Form 8-K on July 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - California Resources Corp (0001609253) (Filer)
California Resources Corp filed a Form 8-K on July 14, 2026, disclosing its results of operations and financial condition for the most recent reporting period.
- 8-K - FLYEXCLUSIVE INC. (0001843973) (Filer)
FlyExclusive Inc. filed a Form 8-K on July 14, 2026 reporting a material definitive agreement, the completion of an acquisition or asset disposition, and accompanying financial statements and exhibits.
- 8-K - FIRST BANCORP /NC/ (0000811589) (Filer)
First Bancorp filed an 8-K on July 14, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.
- 8-K - Federal Home Loan Bank of Indianapolis (0001331754) (Filer)
On July 14, 2026, Federal Home Loan Bank of Indianapolis filed a Form 8-K indicating it has created a direct financial obligation (or an off-balance-sheet arrangement) as disclosed in Item 2.03 of the filing.
- 8-K - Holley Inc. (0001822928) (Filer)
Holley Inc. filed a Form 8-K on July 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - SS Innovations International, Inc. (0001676163) (Filer)
SS Innovations International, Inc. filed a Form 8-K on July 14, 2026 reporting director and officer departures, appointments, compensatory arrangements, and including financial statements and related exhibits.
- 8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer)
Syndax Pharmaceuticals Inc. filed a Form 8-K with the SEC on July 14, 2026 (Accession No. 0001193125-26-302608), including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Runway Growth Finance Corp. (0001653384) (Filer)
Runway Growth Finance Corp. filed a Form 8-K with the SEC on July 14 2026, providing a Regulation FD Disclosure under Item 7.01.
- 8-K - DIODES INC /DEL/ (0000029002) (Filer)
Diodes Inc filed a Form 8-K on July 14, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and related exhibits.
- 8-K - VYNE Therapeutics Inc. (0001566044) (Filer)
VYNE Therapeutics Inc. filed a Form 8-K on July 14 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - Inhibikase Therapeutics, Inc. (0001750149) (Filer)
Inhibikase Therapeutics filed a Form 8-K on July 14, 2026, covering Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits); the filing (accession 0001193125-26-302580) is 157 KB.
- 8-K - FASTENAL CO (0000815556) (Filer)
Fastenal Co filed a Form 8-K on July 14, 2026, reporting its results of operations and financial condition for the period and providing related financial statements and exhibits.
- 8-K - IMMUNIC, INC. (0001280776) (Filer)
Immune, Inc. filed a Form 8-K on July 14, 2026, including a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - RE/MAX Holdings, Inc. (0001581091) (Filer)
RE/MAX Holdings, Inc. filed a Form 8-K with the SEC on July 14 2026, disclosing an Item 8.01 “Other Events” filing.
- 8-K - Cingulate Inc. (0001862150) (Filer)
Cingulate Inc. filed a Form 8-K on July 14, 2026 reporting director and officer departures, appointments, compensatory arrangements, a shareholder vote, and accompanying financial statements and exhibits.
- 8-K - Virtu Financial, Inc. (0001592386) (Filer)
Virtu Financial filed a Form 8-K on July 14, 2026, including Item 2.02 covering its results of operations and financial condition and Item 7.01 containing a Regulation FD disclosure.
- 8-K - Valion Bio, Inc. (0001787740) (Filer)
Valion Bio, Inc. filed a Form 8-K with the SEC on July 14, 2026 (Accession No. 0001683168-26-005497), containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - HCA Healthcare, Inc. (0000860730) (Filer)
HCA Healthcare filed a Form 8-K on July 14, 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.
- 8-K - BREAD FINANCIAL HOLDINGS, INC. (0001101215) (Filer)
Bread Financial Holdings filed a Form 8-K on July 14, 2026 reporting director/officer departures and appointments, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Lulu's Fashion Lounge Holdings, Inc. (0001780201) (Filer)
Lulu's Fashion Lounge Holdings, Inc. filed a Form 8-K on July 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.